Chiral separation of beta blocker pindolol enantiomers

contributed by YMC | 06/11/2015

Pindolol is a non-selective beta-blocker used for treatment of hypertension and angina pectoris. It is applied as a racemate, although only the (S)-form is the active stereoisomer.

YMC offers immobilised chiral phases that can be used either in normal or reversed phase mode as well as in SFC mode. CHIRAL ART Cellulose-SC is a very versatile phase to separate many chiral substances. YMC have developed two isocratic applications to separate the pindolol enantiomers in NP or RP mode. Both methods offer a high resolution. The NP application provides more potential for a preparative scale up, while the RP approach separates the enantiomers in a shorter time.

Log in or register to read this article in full and gain access to The Analytical Scientist’s entire content archive. It’s FREE!

Email*

Choose a password

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

Receive communication from The Cannabis Scientist I want to stay up to date with the Mass Spectrometry field I want to stay up to date with the Spectroscopy field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.